Skip to main content
Back to feed
MarketsSingle-sourceLow
2.1

Blau Farmaceutica shares decline 6% following Goldman Sachs double downgrade

Blau Farmaceutica (BLAU3) shares dropped 6% after Goldman Sachs downgraded the stock by two notches. The downgrade is driven by expectations of earnings deceleration due to challenging year-over-year comparisons.

InfoMoney2 days agoBRCredibility 47%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.5

Intelligence Tags

#blau3#equities#brazil#goldman sachs#pharma

Locations

Brazil

Entities

country
Source

Related signals

8 found